Aktis Oncology Stock Forward View - Accumulation Distribution
| AKTS Stock | USD 17.63 0.32 1.78% |
Aktis Stock outlook is based on your current time horizon.
At this time the rsi of Aktis Oncology's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Aktis Oncology hype-based prediction, you can estimate the value of Aktis Oncology Common from the perspective of Aktis Oncology response to recently generated media hype and the effects of current headlines on its competitors.
Aktis Relative Strength Index
Aktis Oncology Common Hype to Price Pattern
Investor biases related to Aktis Oncology's public news can be used to forecast risks associated with an investment in Aktis. The trend in average sentiment can be used to explain how an investor holding Aktis can time the market purely based on public headlines and social activities around Aktis Oncology Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aktis Oncology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aktis Oncology.
Aktis Oncology after-hype prediction price | USD 18.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Aktis Oncology to cross-verify your projections. Aktis Oncology Additional Predictive Modules
Most predictive techniques to examine Aktis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aktis using various technical indicators. When you analyze Aktis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 4246.35 | 2791.98 |
| Check Aktis Oncology Volatility | Backtest Aktis Oncology | Information Ratio |
Aktis Oncology Trading Date Momentum
| On February 18 2026 Aktis Oncology Common was traded for 17.63 at the closing time. The top price for the day was 18.18 and the lowest listed price was 17.56 . The trading volume for the day was 81.9 K. The trading history from February 18, 2026 did not affect price variability. The overall trading delta against the current closing price is 2.27% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Aktis Oncology to competition |
Other Forecasting Options for Aktis Oncology
For every potential investor in Aktis, whether a beginner or expert, Aktis Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aktis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aktis. Basic forecasting techniques help filter out the noise by identifying Aktis Oncology's price trends.Aktis Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aktis Oncology stock to make a market-neutral strategy. Peer analysis of Aktis Oncology could also be used in its relative valuation, which is a method of valuing Aktis Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aktis Oncology Market Strength Events
Market strength indicators help investors to evaluate how Aktis Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aktis Oncology shares will generate the highest return on investment. By undertsting and applying Aktis Oncology stock market strength indicators, traders can identify Aktis Oncology Common entry and exit signals to maximize returns.
| Accumulation Distribution | 2791.98 | |||
| Daily Balance Of Power | (0.52) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 17.87 | |||
| Day Typical Price | 17.79 | |||
| Price Action Indicator | (0.40) | |||
| Period Momentum Indicator | (0.32) |
Aktis Oncology Risk Indicators
The analysis of Aktis Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aktis Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aktis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.04 | |||
| Standard Deviation | 4.22 | |||
| Variance | 17.82 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Aktis Oncology
The number of cover stories for Aktis Oncology depends on current market conditions and Aktis Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aktis Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aktis Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aktis Oncology Short Properties
Aktis Oncology's future price predictability will typically decrease when Aktis Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aktis Oncology Common often depends not only on the future outlook of the potential Aktis Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aktis Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 89.1 M | |
| Cash And Short Term Investments | 297.2 M |
Additional Tools for Aktis Stock Analysis
When running Aktis Oncology's price analysis, check to measure Aktis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aktis Oncology is operating at the current time. Most of Aktis Oncology's value examination focuses on studying past and present price action to predict the probability of Aktis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aktis Oncology's price. Additionally, you may evaluate how the addition of Aktis Oncology to your portfolios can decrease your overall portfolio volatility.